ALT
NASDAQ · Biotechnology
Altimmune Inc
$3.05
+0.04 (+1.33%)
Open$3.05
Previous Close$3.01
Day High$3.08
Day Low$3.00
52W High$6.44
52W Low$2.56
Volume—
Avg Volume6.07M
Market Cap595.09M
P/E Ratio—
EPS$-0.92
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
+245.9% upside
Current
$3.05
$3.05
Target
$10.55
$10.55
$6.68
$10.55 avg
$11.58
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 97.6K | 232.2K | 252.74M |
| Net Income | -195,092,259 | -932,514,656 | 22.15M |
| Profit Margin | -214,861.0% | -451,530.3% | 8.8% |
| EBITDA | -209,003,728 | -1,065,342,972 | 31.01M |
| Free Cash Flow | — | — | 16.83M |
| Rev Growth | — | -83.5% | +1.7% |
| Debt/Equity | 0.15 | — | 0.20 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |